UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis

PloS one, 2020-12, Vol.15 (12), p.e0243428-e0243428

2020

Volltextzugriff (PDF)

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

Journal of the International AIDS Society, 2010-09, Vol.13 (1), p.35-35

2010

Volltextzugriff (PDF)

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

Gates open research, 2018, Vol.2, p.35-35

2018

Volltextzugriff (PDF)

25 years of the WHO essential medicines lists: progress and challenges

The Lancet (British edition), 2003-05, Vol.361 (9370), p.1723-1729

2003

Volltextzugriff (PDF)

Asia emerges as a hotbed of diagnostic innovations for tuberculosis

Journal of clinical tuberculosis and other mycobacterial diseases, 2021-12, Vol.25, p.100267-100267, Article 100267

2021

Volltextzugriff (PDF)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

Gates open research, 2020, Vol.4, p.24

2020

Volltextzugriff (PDF)

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases

Bulletin of the World Health Organization, 2009-07, Vol.87 (7), p.520-528

2009

Volltextzugriff (PDF)

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

Globalization and health, 2010-05, Vol.6 (1), p.9-9

2010

Volltextzugriff (PDF)

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children

BMC pediatrics, 2010-10, Vol.10 (1), p.74-74, Article 74

2010

Volltextzugriff (PDF)

Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan

BMC health services research, 2010-07, Vol.10 (1), p.205-205, Article 205

2010

Volltextzugriff (PDF)

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

Gates open research, 2018-07, Vol.2, p.35

2018

Volltextzugriff (PDF)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

Gates open research, 2020, Vol.4, p.24

2020

Volltextzugriff (PDF)

Improving equitable access for effective antibacterial: an ecosystem approach

Clinical microbiology and infection, 2024-06

2024

Volltextzugriff (PDF)

Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan

International journal for equity in health, 2009-12, Vol.8 (1), p.43-43

2009

Volltextzugriff (PDF)

New Drugs and Regimens for Tuberculosis Disease Treatment in Children and Adolescents

Journal of the Pediatric Infectious Diseases Society, 2022-10, Vol.11 (Supplement_3), p.S101-S109

2022

Volltextzugriff (PDF)

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector

Microbes and infection, 2020-11, Vol.22 (10), p.511-514

2020

Volltextzugriff (PDF)

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016: version 2; peer review: 4 approved

Gates open research, 2018-09

2018

Volltextzugriff (PDF)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers: version 2; peer review: 2 approved

Gates open research, 2020-04

2020

Volltextzugriff (PDF)

Assessing the population health impact of market interventions to improve access to antiretroviral treatment

Health policy and planning, 2012-09, Vol.27 (6), p.467-476

2012

Volltextzugriff (PDF)

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases/Strategies mondiales pour reduire le prix des medicaments antiretroviraux : elements provenant des bases de donnees de transaction/Estrategias mundiales de reduccion del precio de los antirretrovirales: evidencia extraida de bases de datos transaccionales

Bulletin of the World Health Organization, 2009-07, Vol.87 (7), p.520

2009

Volltextzugriff (PDF)

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases

Bulletin of the World Health Organization, 2009-07, Vol.87 (7), p.520-528

2009

Volltextzugriff (PDF)

Temporal trends in generic and brand prices of antiretroviral medicines procured with donor funds in developing countries

Journal of generic medicines, 2010-04, Vol.7 (2), p.159-175

2010

Volltextzugriff (PDF)

Confidence about an odds ratio

American journal of health-system pharmacy, 1999-10, Vol.56 (19), p.1989-1990

1999

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)

Publikationsform

Artikel
(23)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

25 years of the WHO essential medicines lists: progress and challenges

Asia emerges as a hotbed of diagnostic innovations for tuberculosis

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children

Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers

Improving equitable access for effective antibacterial: an ecosystem approach

Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan

New Drugs and Regimens for Tuberculosis Disease Treatment in Children and Adolescents

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016: version 2; peer review: 4 approved

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers: version 2; peer review: 2 approved

Assessing the population health impact of market interventions to improve access to antiretroviral treatment

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases

Temporal trends in generic and brand prices of antiretroviral medicines procured with donor funds in developing countries

Confidence about an odds ratio

Aktive Filter

Suchergebnisse filtern